<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03892590</url>
  </required_header>
  <id_info>
    <org_study_id>Gut Microbiota</org_study_id>
    <nct_id>NCT03892590</nct_id>
  </id_info>
  <brief_title>Gut Microbiota Pilot Study</brief_title>
  <official_title>Anaylsis of Gut Microbiota in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Armed Forces Goyang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Armed Forces Goyang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Microbiota is known to effect metabolism. This is pilot study to get status of microbiota
      from normal control. It will be compared to data from specific patients in ICU via further
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microbiota is known to effect metabolism. Patients in specific conditions like hypovolemic
      shock, sepsis might have changes in status of microbiota. This is pilot study to get status
      of microbiota from normal control. Stable patient who are admitted to ICU for observation
      will be gathered. Samples will be collected via rectal swab at time of admission and analyzed
      via Next generation sequencing.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Normal microbiota</measure>
    <time_frame>1day</time_frame>
    <description>Status of microbiota of stable patient in ICU</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Microbiota</condition>
  <condition>Metabolism</condition>
  <arm_group>
    <arm_group_label>Stable patient</arm_group_label>
    <description>Stable patients who admitted to ICU for observation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gut microbiota</intervention_name>
    <description>Status of microbiota</description>
    <arm_group_label>Stable patient</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Stable adult patient who are admitted to ICU
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 17 years old

          -  Every patients who are admitted to ICU

        Exclusion Criteria:

          -  With history of disease such as cancer, Crohn's disease, ulcerative colitis, irritable
             bowel syndrome

          -  With history of immunosuppressive agents.

          -  Initial systolic blood pressure &lt;100

          -  Initial pulse rate &gt; 100

          -  Need emergent operation at brain or torso

          -  Need vasopressor, transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maru Kim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>M Kim, MD, PhD</last_name>
    <phone>82318266246</phone>
    <email>maru@catholic.ac.kr</email>
  </overall_contact>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Maru Kim</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

